175 related articles for article (PubMed ID: 10834427)
1. Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.
Korpinen E; Teppo AM; Hukkanen L; Akerblom HK; Grönhagen-Riska C; Vaarala O
Diabetes Care; 2000 May; 23(5):664-8. PubMed ID: 10834427
[TBL] [Abstract][Full Text] [Related]
2. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
3. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
Ellis D; Forrest KY; Erbey J; Orchard TJ
Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
[TBL] [Abstract][Full Text] [Related]
4. Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome.
Teppo AM; Honkanen E; Finne P; Törnroth T; Grönhagen-Riska C
Transplantation; 2004 Sep; 78(5):719-24. PubMed ID: 15371675
[TBL] [Abstract][Full Text] [Related]
5. Urinary α
Saif A; Soliman N
J Diabetes; 2017 Jan; 9(1):61-64. PubMed ID: 26847470
[TBL] [Abstract][Full Text] [Related]
6. Urinary transforming growth factor-beta 1 in various types of nephropathy.
De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
[TBL] [Abstract][Full Text] [Related]
7. The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus.
Flores L; Vidal M; Abian J; Cases A; Campistol JM; Clària J; Lario S; Esmatjes E
Diabet Med; 2004 Mar; 21(3):285-9. PubMed ID: 15008841
[TBL] [Abstract][Full Text] [Related]
8. Changes of urinary alpha1-microglobulin in the assessment of prognosis in renal transplant recipients.
Teppo AM; Honkanen E; Ahonen J; Grönhagen-Riska C
Transplantation; 2000 Oct; 70(8):1154-9. PubMed ID: 11063333
[TBL] [Abstract][Full Text] [Related]
9. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
10. Urinary transforming growth factor-β1 in children with obstructive uropathy.
Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
[TBL] [Abstract][Full Text] [Related]
11. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
12. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
13. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
Galanti LM; Jamart J; Dell'omo J; Donckier J
Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
[TBL] [Abstract][Full Text] [Related]
14. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
15. Activation of transforming growth factor-beta1 in diabetic kidney disease.
Hellmich B; Schellner M; Schatz H; Pfeiffer A
Metabolism; 2000 Mar; 49(3):353-9. PubMed ID: 10726914
[TBL] [Abstract][Full Text] [Related]
16. Correlation of urinary albumin and beta-2-microglobulin and growth hormone excretion in patients with diabetes mellitus and short stature.
Pan FP; Stevenson JL; Donaldson DL; Levy J; Wiegmann T; Moore WV
J Clin Endocrinol Metab; 1990 Sep; 71(3):611-7. PubMed ID: 2203797
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of pancreatic stone protein in diabetic nephropathy.
Sobajima H; Niwa T; Shikano M; Naruse S; Kitagawa M; Nakae Y; Ishiguro H; Kondo T; Hayakawa T
Intern Med; 1998 Jun; 37(6):500-3. PubMed ID: 9678681
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.
Flores L; Näf S; Hernáez R; Conget I; Gomis R; Esmatjes E
Diabet Med; 2004 Aug; 21(8):818-22. PubMed ID: 15270783
[TBL] [Abstract][Full Text] [Related]
19. Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.
Esmatjes E; Flores L; Iñigo P; Lario S; Ruilope LM; Campistol JM
Nephrol Dial Transplant; 2001; 16 Suppl 1():90-3. PubMed ID: 11369831
[TBL] [Abstract][Full Text] [Related]
20. [Increased urinary excretion of transforming growth factor beta and interleukin-6 in patients with diabetic nephropathy].
Królak R; Paczek L; Rogala H; Bartłomiejczyk I; Gradowska L; Korczak D; Gaciong Z
Pol Arch Med Wewn; 1996 Dec; 96(6):545-51. PubMed ID: 9139274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
